“The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.” BCC Research – ROI in Pharmaceutical R&D: How to Halt the Decline

BCC Research
• Nanotechnology in Cancer Treatment (March 2020)
• Hyperkalemia Market: A BCC Research Perspective (February 2020)
• Medical Affairs: The Roadmap to 2025 (February 2020)
• Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future (January 2020)
• ROI in Pharmaceutical R&D: How to Halt the Decline (January 2020)

Frost & Sullivan
• Technological Advances in Digital Healthcare, Coronavirus Research, and Global Life Sciences Industries (February 2020)
• EU Healthcare Predictions and Outlook, 2020 (February 2020)
• Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025 (January 2020)
• Novel Enzyme Technologies for Pharmaceutical Applications (December 2019)
• Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025 (October 2019)

Datamonitor
• Market Spotlight: Celiac Disease (February 2020)
• Biosimilars in the US and Europe (June 2019)
• Top 10 Best-Selling Drugs of 2018 Fund US and EU Pharma R&D (May 2019)
• A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis (April 2019)
• Gene Therapy Pipeline and Portfolio Analysis (April 2019)

Gartner
• The Evolution of Healthcare Consumer Engagement Hub Architecture (February 2020)
• An Assessment of Global Regulations Across the Healthcare Value Chain Requiring Track and Trace With Serialization (February 2020)
• Healthcare Business Driver: Medical Innovations in Therapy, Diagnosis and Care Delivery (January 2020)
• IT Key Metrics Data 2020: Industry Measures —Pharmaceuticals, Life Sciences and Medical Products Analysis (December 2019)
• Supply Chain Benchmarking Data Reveals Differences Between Pharmaceutical and Medical Device Manufacturers (November 2019)

Euromonitor
• Understanding Consumers’ Behaviour-Led Habits in Health and Nutrition (February 2020)
• Where Consumers Shop for Consumer Health (January 2020)
• What to Expect in the 2019/2020 Cold and Flu Season (December 2019)
• World Market for Consumer Health Products (October 2019)

EBSCO
Why Do Experts Solve Complex Problems Using Open Innovation? Evidence from the U.S. Pharmaceutical Industry.
By: Lee, Yeolan; Fong, Eric; Barney, Jay Bryan; Hawk, Ashton. California Management Review. Nov2019, Vol. 62 Issue 1, p144-166. 23p. 1 Diagram, 6 Charts, 2 Graphs. DOI: 10.1177/0008125619883617. , Database: Business Source Corporate Plus
Big pharma takes apart the OECD on marketing intangibles.
By: White, Josh. International Tax Review. 1/20/2020, pN.PAG-N.PAG. 1p. , Database: Business Source Corporate Plus

 

Important note: All databases are subject to copyright which will be explained to clients on their visit. The use of cameras and USBs in the Centre is strictly prohibited.

This website uses cookies to improve our website, provide more personalised services to you and analyse our traffic. To find out more information about our use of cookies please read our Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close